Literature DB >> 7695913

Generation of amyloid beta protein from its precursor is sequence specific.

M Citron1, D B Teplow, D J Selkoe.   

Abstract

Cerebral deposition of amyloid beta protein (A beta) is an early and critical feature of Alzheimer's disease. Here we analyze the substrate requirements of proteases ("beta-secretases") that cleave the beta-amyloid precursor protein (beta APP) at the N-terminus of A beta (Asp-597 of beta APP695) in intact human cells. The cleavage requires a membrane-bound substrate but tolerates shifts in the distance of the hydrolyzed bond from the membrane. The major protease has a minimum recognition region of Val-594 to Ala-598; most substitutions in this sequence strongly decrease or eliminate A beta production. Only the Swedish familial Alzheimer's disease mutation (K595N/M596L) strongly increases A beta production. Moreover, in this mutant but not in the wild type, the entire cytoplasmic tail with its reinternalization signals can be deleted without affecting A beta N-terminal cleavage, consistent with the concept that cleavage of this mutant occurs in a different cellular compartment than that of wild-type molecules. Our results have important implications for current intensive approaches to develop assays for and identify enzymes with beta-secretase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695913     DOI: 10.1016/0896-6273(95)90323-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  68 in total

1.  Novel functional assay for proteases and modulators. Application in beta-secretase studies.

Authors:  Y Li; Y W Liu; B Cordell
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

2.  Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase.

Authors:  S Kitazume; Y Tachida; R Oka; K Shirotani; T C Saido; Y Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.

Authors:  M Farzan; C E Schnitzler; N Vasilieva; D Leung; H Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

4.  Novel GαS-protein signaling associated with membrane-tethered amyloid precursor protein intracellular domain.

Authors:  Carole Deyts; Kulandaivelu S Vetrivel; Shibandri Das; Yumiko M Shepherd; Denis J Dupré; Gopal Thinakaran; Angèle T Parent
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

5.  PTEN recruitment controls synaptic and cognitive function in Alzheimer's models.

Authors:  Shira Knafo; Cristina Sánchez-Puelles; Ernest Palomer; Igotz Delgado; Jonathan E Draffin; Janire Mingo; Tina Wahle; Kanwardeep Kaleka; Liping Mou; Inmaculada Pereda-Perez; Edvin Klosi; Erik B Faber; Heidi M Chapman; Laura Lozano-Montes; Ana Ortega-Molina; Lara Ordóñez-Gutiérrez; Francisco Wandosell; Jose Viña; Carlos G Dotti; Randy A Hall; Rafael Pulido; Nashaat Z Gerges; Andrew M Chan; Mark R Spaller; Manuel Serrano; César Venero; José A Esteban
Journal:  Nat Neurosci       Date:  2016-01-18       Impact factor: 24.884

6.  Full-length cellular β-secretase has a trimeric subunit stoichiometry, and its sulfur-rich transmembrane interaction site modulates cytosolic copper compartmentalization.

Authors:  Filip Liebsch; Mark R P Aurousseau; Tobias Bethge; Hugo McGuire; Silvia Scolari; Andreas Herrmann; Rikard Blunck; Derek Bowie; Gerd Multhaup
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

Review 7.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 8.  The beta-secretase, BACE: a prime drug target for Alzheimer's disease.

Authors:  R Vassar
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

9.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

Review 10.  Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease.

Authors:  Wioletta Rozpedek; Lukasz Markiewicz; J Alan Diehl; Dariusz Pytel; Ireneusz Majsterek
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.